Depressive symptoms predict non-completion of a structured exercise intervention for people with Type 2 diabetes

Diabet Med. 2016 Apr;33(4):529-36. doi: 10.1111/dme.12872. Epub 2015 Aug 25.

Abstract

Aim: To quantify the impact of depressive symptoms on completion of exercise-based rehabilitation for Type 2 diabetes management.

Methods: Depressive symptoms were assessed using the Center for Epidemiological Studies Depression scale in a prospective cohort of consecutive patients with Type 2 diabetes entering a 6-month hybrid (home- and clinic-based) exercise rehabilitation programme. Attendance at exercise sessions was monitored and programme completion/non-completion was ascertained.

Results: Of the programme participants (n=624, mean age 55.6±10.5 years, 47% male), 26.8% endorsed significant depressive symptoms (depression score ≥16) and 68.1% completed the intervention, attending 54.6±30.0% of supervised exercise sessions. Baseline depressive symptoms (depression scale score ≥16) increased the risk of non-completion [hazard ratio 1.49 (95% CI 1.10-2.03); P = 0.010], and predicted fewer sessions attended (β=-2.1, P= 0.002) in adjusted models. A depression score threshold of ≥10 (48.4% of participants) predicted non-completion [hazard ratio 1.60 (95% CI 1.19-2.17); P= 0.002) with optimum accuracy. Non-completions resulting from lack of interest (18.9 vs. 11.0%; P= 0.026) and medical complications (14.6 vs. 6.6%; P= 0.006) were more common among participants with depression scores ≥10. Greater hazard ratios for depression scores ≥10 were observed in subgroups not currently using insulin [hazard ratio 1.70 (95% CI 1.24-2.33); P= 0.001), or an antidepressant [hazard ratio 1.83 (95% CI 1.32-2.54); P<0.001].

Conclusions: Depressive symptoms were highly prevalent among participants with Type 2 diabetes entering exercise-based rehabilitation, and even mild depressive symptoms posed a significant barrier to completion. Depression screening may help target additional supports to facilitate completion of exercise interventions for people with Type 2 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antidepressive Agents / therapeutic use
  • Cohort Studies
  • Depression / complications*
  • Depression / drug therapy
  • Depression / epidemiology
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / psychology*
  • Diabetic Cardiomyopathies / complications
  • Diabetic Cardiomyopathies / rehabilitation*
  • Exercise Therapy*
  • Female
  • Heart Diseases / complications
  • Heart Diseases / rehabilitation*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin / therapeutic use
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Ontario / epidemiology
  • Patient Compliance*
  • Prevalence
  • Proportional Hazards Models
  • Prospective Studies
  • Psychiatric Status Rating Scales
  • Risk

Substances

  • Antidepressive Agents
  • Hypoglycemic Agents
  • Insulin